There are 2949 resources available
335P - Resistance to CDK4/6 inhibitors: Clinical practice use of liquid biopsy to identify KRAS-mutations in ctDNA and overexpression of CDK9 in plasma derived exosomes
Presenter: Lucrezia Raimondi
Session: E-Poster Display
Resources:
Abstract
336P - PI3K pathway biomarkers and clinical response in a phase I/Ib study of GDC-0077 in hormone receptor-positive/HER2-negative breast cancer (HR+/HER2– BC)
Presenter: Valentina Gambardella
Session: E-Poster Display
Resources:
Abstract
337P - Efficacy of everolimus plus exemestane in CDK 4/6 inhibitors-pretreated or naïve HR-positive/HER2-negative breast cancer patients: A secondary analysis of the EVERMET study
Presenter: Federico Nichetti
Session: E-Poster Display
Resources:
Abstract
338P - Defining pathway: A novel analysis of geriatric indigenous women with breast cancer impacting survival and outcomes
Presenter: Azim Khan
Session: E-Poster Display
Resources:
Abstract
339P - Impact of blood glucose levels on the efficacy of everolimus-exemestane in patients with advanced HR-positive/HER2 negative breast cancer: The EVERMET study
Presenter: Claudio Vernieri
Session: E-Poster Display
Resources:
Abstract
340P - Patient preferences for HER2-targeted treatment of advanced or metastatic breast cancer in the United States
Presenter: Carol Mansfield
Session: E-Poster Display
Resources:
Abstract
341P - Does race impact outcomes in triple negative breast cancer?
Presenter: Kevin Holcomb
Session: E-Poster Display
Resources:
Abstract
342P - Different modalities of detection breast cancer recurrences: A 5-year retrospective cohort study
Presenter: Diego Zara
Session: E-Poster Display
Resources:
Abstract
343P - Metronomic oral vinorelbine (MOV) combined with tremelimumab (T) + durvalumab (D): Efficacy and safety preliminary results of the advanced breast cancer (ABC) patients (pts) cohort of the MOVIE study
Presenter: Thibault de La Motte Rouge
Session: E-Poster Display
Resources:
Abstract
344P - Clinical outcomes of platinum-based polichemotherapy in patients with advanced breast cancer: A 10-year single institutional experience
Presenter: Maria Alice Franzoi
Session: E-Poster Display
Resources:
Abstract